Infectious disease

Horizontal Technology Programme Offices will bring A*STAR’s deep capabilities to bear on real-world issues facing Singapore and the wider world, says Deputy Chief Executive (Research), Andy Hor.

Plant-based ionizers are surprisingly effective at removing aerosols and could play an important role in preventing COVID-19 transmission.

New clues into how the immune system remembers a dengue infection may lead to a better vaccine.

Antiviral strategies against COVID-19 broadly fall into two groups: those that target the virus and those that target the host factors that are essential for virus replication.

Tipped off by artificial intelligence, a research team is testing whether a rheumatoid arthritis drug could be repurposed as a COVID-19 treatment.

Researchers at A*STAR have uncovered a new role for a subset of immune cells in HIV infection and transmission.

Targeted mutagenesis is being used to create live-attenuated vaccines against the chikungunya virus.

A*STAR researchers have identified four peptide sequences that distinguish the Zika virus from other flaviviruses, with implications for diagnostics and vaccine development.

The antiviral protein Viperin keeps immune cells in check to prevent joint swelling during chikungunya virus infection.

A deadly bacterium uses cellular proteins as bait to sabotage a pathway that enables immune response

A joint research center at the A*STAR Institute of Bioengineering and Nanotechnology aims to improve infectious disease diagnostics

The infection of one dengue virus subtype can lead to the production of antibodies that confer protection against other dengue virus subtypes